Causal relationships between peripheral immune cells and Alzheimer's disease: a two-sample Mendelian randomization
Jing Liao1, Yongquan Zhang2, Zhanhong Tang3
1Ruikang Hospital, Affiliated to Guangxi University of Chinese Medicine, 10 Huadong Road, Xingning District, Nanning City, Guangxi, 53000, China. 1294199586@qq.com.
Peripheral immune cell composition causally influences Alzheimer's disease (AD) risk. Specific immune cell increases are linked to higher AD susceptibility, while others show a protective effect, offering new diagnostic and therapeutic avenues.
Area of Science:
- Immunology
- Neuroscience
- Genetics
Background:
- Peripheral immune cells are increasingly implicated in neurodegenerative diseases.
- The specific contribution of peripheral immune cell composition to Alzheimer's disease (AD) pathogenesis remains unclear.
Purpose of the Study:
- To investigate the causal relationship between peripheral immune cell composition and the risk of developing AD.
- To identify specific immune cell types associated with increased or decreased AD susceptibility.
Main Methods:
- A two-sample Mendelian randomization (MR) approach was employed to assess the association between peripheral immune cells and AD.
- Primary analysis utilized the inverse variance weighted (IVW) method, with supporting analyses from MR-Egger, weighted median, and mode-based methods.
- Heterogeneity and horizontal pleiotropy were assessed using Cochran's Q statistics and the MR-Egger intercept.
Main Results:
- Increased IgD+CD24- AC cells, CD4+ %leukocyte, and CD4+CD8dim AC cells were significantly associated with higher AD susceptibility (ORs ranging from 1.03 to 1.08).
- Conversely, increased EM DN (CD4-CD8-) %T cells and DN (CD4-CD8-) AC cells showed a protective effect against AD (ORs of 0.95 and 0.93, respectively).
Conclusions:
- This study provides the first evidence of a causal link between peripheral immune cell composition and AD using MR.
- Findings highlight specific immune cell populations as potential biomarkers for AD risk and therapeutic targets.
More Related Videos
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
08:43Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
